)
Visual21 Nov 2025
Data center suppliers
Navamedic (NAVA) investor relations material
Navamedic Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary28 Oct, 2025
Executive summary
Q3 2025 revenues reached 138.9 MNOK, up 12.9% year-over-year, with growth across all business areas and the integration of the dne Pharma acquisition progressing as planned.
Completed acquisition of dne Pharma business in July, adding 10.6 MNOK in Rx revenues and expanding the portfolio into addiction treatment.
Gross margin improved to 37.5% from 37.1% in Q3 2024, driven by product mix and currency effects.
Adjusted EBITDA (excluding transaction costs) rose to 11.3 MNOK from 8.6 MNOK in Q3 2024.
Rights issue completed in October, raising 130 MNOK to support the dne acquisition.
Financial highlights
Operating revenues for Q3 2025 were 138.9 MNOK, up from 123.1 MNOK in Q3 2024.
Operating costs were 40.8 MNOK, up from 37.1 MNOK year-over-year.
EBIT for Q3 2025 was negative 0.2 MNOK, mainly due to amortization of acquired intangible assets.
Net financial items were negative 3.6 MNOK, mainly due to interest, currency, and Observe Medical loans/shares.
Cash at quarter-end was 51.7 MNOK, up from 46.5 MNOK a year earlier.
Outlook and guidance
Commercial launch of Flexilev in OraFID across the Nordics planned for Q4 2025, with further European expansion through a license and supply agreement.
Equity ratio expected to recover in Q4 after bridge financing for the dne acquisition.
Growth strategy focuses on unlocking existing product potential, outlicensing, further M&A, and building towards a 1 billion NOK revenue ambition.
Continued growth and expansion opportunities, especially in addiction treatment and antibiotics portfolios.
Strategic rationale for addiction focus?
Reconcile negative Q3 EBIT with 1BNOK ambition.
What is Orafid's role in the Parkinson's portfolio?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Navamedic earnings date
Q4 202512 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Navamedic ASA is a Norwegian pharmaceutical company focused on developing, producing, marketing, and distributing a range of healthcare products. Its portfolio includes both prescription and non-prescription pharmaceuticals, medical nutrition products, medical devices, and consumer health items such as food supplements and cosmetics. The company primarily serves hospitals, pharmacies, and patients across the Nordic countries, Benelux, and the Baltics, with additional presence in the UK and other European markets. The company is headquartered in Oslo, Norway, and its shares are listed on the Oslo Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage